What are the side effects of topiramate?

Side Effects of Topiramate

Topiramate carries a significant adverse effect burden that clinicians must discuss thoroughly with patients before initiation, with the most concerning being metabolic acidosis, acute angle-closure glaucoma, cognitive impairment, and teratogenicity. 1

Serious Side Effects Requiring Immediate Action

Metabolic Acidosis

• Presents with tiredness, loss of appetite, irregular heartbeat, and impaired consciousness
• Requires baseline and periodic serum bicarbonate monitoring throughout treatment
• Can occur at any point during therapy 1

Acute Vision-Threatening Events

• Secondary angle-closure glaucoma and acute myopia can develop suddenly
• Symptoms: sudden vision loss with or without eye pain
• Can lead to permanent blindness if not recognized immediately
• Requires immediate discontinuation and ophthalmologic evaluation 1

Oligohidrosis and Hyperthermia

• Decreased sweating leading to dangerous elevation in body temperature
• Particularly dangerous in children and during hot weather or exercise
• May require hospitalization 1, 2
• Monitor closely during heat exposure and physical activity

Cognitive and Neuropsychiatric Effects

The most common reason patients discontinue topiramate is CNS-related adverse effects 3:

• Cognitive slowing and impaired concentration (reported in 21.7% of pediatric patients) 4
• Problems with attention, memory, and speech
• Word-finding difficulties and hesitant speech 5
• Confusion and decreased alertness
• Depression and mood problems
• Tiredness and sleepiness
• Rare cases of drug-induced amnesia (dose-dependent and reversible) 6

The 2025 American College of Physicians guideline specifically notes that topiramate has an "unfavorable tolerability profile" compared to β-blockers and CGRP monoclonal antibodies, with a higher number of adverse events that influenced recommendations away from topiramate as a first-line agent 3.

Common Side Effects (Generally Mild to Moderate)

Neurological

• Paresthesia (tingling of arms and legs) - very common 1
• Dizziness
• Ataxia and loss of muscle coordination 1

Gastrointestinal and Metabolic

• Loss of appetite and weight loss (can be therapeutic in obesity management)
• Nausea
• Change in taste (dysgeusia)
• Diarrhea 1

Other

• Upper respiratory tract infection
• Nervousness and aggression 1

Kidney Stones

• Increased risk of nephrolithiasis due to carbonic anhydrase inhibition
• Patients must maintain adequate hydration throughout treatment
• Incidence approximately 1.5% 5
• Most patients who develop stones can continue therapy with increased fluid intake 1

Drug Interactions and Special Warnings

Hyperammonemia

• High blood ammonia levels affecting mental status
• Particularly when combined with valproic acid
• Presents as decreased alertness, fatigue, or vomiting 1

Contraceptive Efficacy

• Topiramate reduces effectiveness of oral contraceptives
• Counsel patients on need for alternative or additional contraception 1

Teratogenicity

• Documented teratogenic effects - discuss with all patients of childbearing potential
• The 2020 pediatric migraine guideline specifically emphasizes discussing teratogenic effects and advising effective birth control plus folate supplementation (Grade A recommendation) 7
• Patients should be enrolled in pregnancy registry if exposed during pregnancy 1

Clinical Considerations for Minimizing Adverse Effects

Most adverse events are dose-related and occur during titration 8, 5, 9:

• Start at low doses and titrate slowly
• Most patients who experience adverse events in the first 8 weeks no longer report them at later visits 5
• The overall incidence of adverse events can be reduced by slower upward dosage titration 9
• Effective doses for migraine prevention are typically 200-400 mg/day, with higher doses offering minimal additional benefit but increased side effects 3

Activities to Avoid

• Avoid alcohol (worsens sleepiness and dizziness)
• Do not drive or operate machinery until effects are known
• Avoid other CNS depressants unless prescribed
• Exercise caution with activities where loss of consciousness could be dangerous (swimming, driving, heights) 1

The cognitive side effects, particularly "mental slowing," are significant enough that the 2025 ACP guideline recommends prioritizing other agents with more favorable adverse effect profiles when efficacy is comparable 3.